Keywords: targacept, gets, 6m, gsk, milestone, ph, clinical-stage

Targacept gets $6M GSK milestone for Ph I

Article | 17 December 2007

Print This

Targacept, a US clinical-stage drug company, has initiated a Phase I clinical trial of its product candidate TC-6499, triggering a $6.0 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in